Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?
- 26 April 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 193 (8) , 1161-1167
Abstract
Individualizing treatment assignment can improve outcomes for diseases with patient-to-patient variability in comparative treatment effects. When a clinical trial demonstrates that some patients improve on treatment while others do not, it is tempting to assume that treatment effect heterogeneity exists. However, if outcome variability is mainly driven by factors other than variability in the treatment effect, investigating the extent to which covariate data can predict differential treatment response is a potential waste of resources. Motivated by recent meta-analyses assessing the potential of individualizing treatment for major depressive disorder using only summary statistics, we provide a method that uses summary statistics widely available in published clinical trial results to bound the benefit of optimally assigning treatment to each patient. We also offer alternate bounds for settings in which trial results are stratified by another covariate. Our upper bounds can be especially informative when they are small, as there is then little benefit to collecting additional covariate data. We demonstrate our approach using summary statistics from a depression treatment trial. Our methods are implemented in the rct2otrbounds R package.Keywords
All Related Versions
Funding Information
- National Institutes of Health (DP2LM013340, R01HL137808, T32ES015459)
- National Science Foundation (DGE-1762114)
This publication has 19 references indexed in Scilit:
- Sharp lower and upper bounds for the covariance of bounded random variablesStatistics & Probability Letters, 2022
- On Algorithmic Fairness in Medical PracticeCambridge Quarterly of Healthcare Ethics, 2022
- RETRACTED: Individual Differences in Response to AntidepressantsJAMA Psychiatry, 2020
- What are the chances for personalised treatment with antidepressants? Detection of patient-by-treatment interaction with a variance ratio meta-analysisBMJ Open, 2019
- Evaluation of Differences in Individual Treatment Response in Schizophrenia Spectrum DisordersJAMA Psychiatry, 2019
- Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practiceThe World Journal of Biological Psychiatry, 2019
- How to Do a Systematic Review: A Best Practice Guide for Conducting and Reporting Narrative Reviews, Meta-Analyses, and Meta-SynthesesAnnual Review of Psychology, 2019
- Sex differences in antidepressant efficacyNeuropsychopharmacology, 2018
- Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC studyPsychological Medicine, 2018
- Estimating Individualized Treatment Rules Using Outcome Weighted LearningJournal of the American Statistical Association, 2012